Toward a patient-centered approach to the well-being of patients with chronic liver disease or liver transplantation
DOI:
https://doi.org/10.59093/27112330.151Keywords:
quality of life, liver diseases, chronic, liver transplantation.Abstract
Quality of life (QoL) is a multidimensional construct that assesses physical status, emotional well-being, social functioning, and the ability to carry out daily activities. Its measurement facilitates shared decision-making, prioritization of multidisciplinary interventions, and the evaluation of outcomes that go beyond biochemical metrics or disease severity. The factors influencing QoL in cirrhosis depend on the degree of liver impairment (compensated vs. decompensated cirrhosis) and on the presence of ascites, encephalopathy, jaundice, or variceal bleeding, as well as comorbidities or symptoms such as sarcopenia/malnutrition, diabetes, hypotension, obesity, kidney disease, fatigue, pain, insomnia, pruritus, and abdominal discomfort. In the sphere of mental health and social support, anxiety, depression, and the strength of family and financial support networks are key determinants. Adverse effects of treatments, adherence, and changes in diet and lifestyle also play a role. Socioeconomic and cultural factors such as access to care, health education, treatment adherence, and the ability to follow care plans are equally important.Downloads
References
Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, Jones DE. Health related quality of life in people with advanced chronic liver disease. J Hepatol 2014;61:1158-65. https://doi.org/10.1016/j.jhep.2014.06.034.
Sun C, Fan JG. Editorial: changes of health-related quality of life associated with liver disease severity and its improvement after treatment in NAFLD. Aliment Pharmacol Ther 2023;57:257-258. https://doi.org/10.1111/apt.17318.
Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999;45:295-300. https://doi.org/10.1136/gut.45.2.295.
Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana José M, et al. El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 2005;19:135-150.
RAND Corporation. 36-Item short form survey (SF-36) scoring instructions; 2025. Acceso 10 de agosto de 2025. Disponible en: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html.
Girgenti R, Tropea A, Buttafarro MA, Ragusa R, Ammirata M. Quality of life in liver transplant recipients: a retropective study. Int J Environ Res Public Health 2020;17:3809. https://doi.org/10.3390/ijerph17113809.
Dąbrowska-Bender M, Kozaczuk A, Pączek L, Milkiewicz P, Słoniewski R, Staniszewska A. Patient quality of life after liver transplantation in terms of emotional problems and the impact of sociodemographic factors. Transplant Proc 2018;50:2031-2038. https://doi.org/10.1016/j.transproceed.2018.03.113.
Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC. Physical function, physical activity, and quality of life after liver transplantation. Liver Transpl 2020;26:702-708. https://doi.org/10.1002/lt.25742.
Berumen J, Helmming A. Liver retransplantation: How much is too much? Clin Liver Dis 2017;21:435-447. https://doi.org/10.1016/j.cld.2016.12.013.
Santos O, Muñoz O, Marín JI y Restrepo JC. Trasplante hepático en un centro de Colombia: comparación de dos períodos. Rev Colomb Gastroenterol 2019;34:117-124. https://doi.org/10.22516/25007440.391.
Takagi K, Domagala P, Porte RJ, Aylwin I, Metselaar HJ, van den Verg AP, et al. Liver retransplantation in adult recipients: Analysis of a 38-year experience in the Netherlands. J Hepatobiliary Pancreat Sci 2020;27:26-33. https://doi.org/10.1002/jhbp.701.
Neuberger J. Follow-up of liver transplant recipients. Best Pract Res Clin Gastroenterol 2020;46-47:101682. https://doi.org/10.1016/j.bpg.2020.101682.
Schiel WA, Uili-Coelho JC, Conde-Watanabe AL, Raeder-DaCosta MA, Pissaia Jr A. Indications and outcomes of liver retransplantation in three medical centers. Rev Col Bras Cir 2024;51:e20243689. https://doi.org/10.1590/0100-6991e-20243689-en.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The authors retain copyright and grant the Colombian Association of Hepatology a non-exclusive right to publish and disseminate their work.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |














